Washington University School Of Medicine
Grant in 2023
Washington University School of Medicine is the medical school of Washington University in St. Louis.A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School’s 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children’s hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.
Washington University School Of Medicine
Grant in 2019
Washington University School of Medicine is the medical school of Washington University in St. Louis.A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School’s 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children’s hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.
University of Missouri
Grant in 2019
The University of Missouri, established in 1839, is a comprehensive public research university located in Columbia, Missouri. It offers over 280 degree programs across various divisions, including Agriculture, Arts and Sciences, Business, Education, Engineering, Medicine, Law, Nursing, and Veterinary Medicine. With a student body of over 30,000, Mizzou provides a diverse range of academic, research, and extracurricular opportunities, with popular programs in Journalism and Writing. The university maintains selective admission standards, considering factors such as GPA, test scores, and extracurricular involvement. It offers academic merit scholarships and federal aid to support students' tuition costs. The university's endowment fund, managed by the executive team, supports scholarships, research, and academic programs across its campuses.
Precision Virologics
Grant in 2019
Precision Virologics, Inc. is a biotechnology company focused on developing biologically targeted vaccines for emerging infectious diseases, including Zika. Established in 2016 and headquartered in Saint Louis, Missouri, the company utilizes an innovative technology based on adenoviral vectors that incorporate camelid antibodies aimed at activated dendritic cells. This approach allows for the precise delivery of proprietary antigen epitopes to target pathogens and offers significant advantages, such as reduced cross-reactivity among flaviviruses and enhanced potency. In addition to its Zika vaccine candidate, PV-ZIKV, Precision Virologics also aims to address other infectious diseases, including chikungunya and dengue, by harnessing its advanced vaccine development capabilities.
Precision Virologics
Grant in 2018
Precision Virologics, Inc. is a biotechnology company focused on developing biologically targeted vaccines for emerging infectious diseases, including Zika. Established in 2016 and headquartered in Saint Louis, Missouri, the company utilizes an innovative technology based on adenoviral vectors that incorporate camelid antibodies aimed at activated dendritic cells. This approach allows for the precise delivery of proprietary antigen epitopes to target pathogens and offers significant advantages, such as reduced cross-reactivity among flaviviruses and enhanced potency. In addition to its Zika vaccine candidate, PV-ZIKV, Precision Virologics also aims to address other infectious diseases, including chikungunya and dengue, by harnessing its advanced vaccine development capabilities.
Intact Genomics
Grant in 2018
Intact Genomics is a biotechnology research and development company specializing in large DNA fragment cloning and metagenomic technologies. Located in the Helix Center Biotech Incubator near prominent institutions such as Monsanto and the Donald Danforth Plant Science Center in St. Louis, the company utilizes advanced equipment and employs dedicated scientists to provide a range of life science products and services. Intact Genomics focuses on large insert DNA cloning, manipulation, and bacterial artificial chromosome library services, facilitating scientists' exploration of the genome structure and function across various microorganisms, plants, and animal species.
SentiAR, Inc. is a digital health company based in St. Louis, Missouri, specializing in 3D augmented reality solutions for interventional medical procedures. Founded in 2017 as a spin-off from Washington University, SentiAR has developed a platform that offers real-time holographic visualization of patients' anatomical structures and catheter locations. This technology integrates data from CT, MRI, and real-time mapping systems to create a controllable 3D holographic interface. The platform aims to enhance the delivery of care by allowing clinicians to visualize complex cardiac anatomy directly over the patient, thereby improving the treatment of cardiac arrhythmias during catheterization procedures. SentiAR is in the process of preparing its platform for submission to the FDA.
Washington University in St. Louis
Grant in 2017
Washington University in St. Louis, established in 1853 and located in Saint Louis, Missouri, is a prestigious institution dedicated to fostering an environment of exploration and discovery. The university emphasizes the importance of diversity, inclusion, and rigorous academic research, aiming to create a vibrant society enriched by varied perspectives. Its mission centers on supporting both individual and collective success within a nurturing and intellectually challenging community. By continuously adapting to the evolving needs of its students, faculty, and alumni, Washington University strives to enhance lives and address significant societal challenges. The university is committed to upholding high standards of excellence, thereby inspiring collaboration and innovation among its members.
Washington University School Of Medicine
Grant in 2017
Washington University School of Medicine is the medical school of Washington University in St. Louis.A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School’s 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children’s hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.
Intact Genomics
Grant in 2016
Intact Genomics is a biotechnology research and development company specializing in large DNA fragment cloning and metagenomic technologies. Located in the Helix Center Biotech Incubator near prominent institutions such as Monsanto and the Donald Danforth Plant Science Center in St. Louis, the company utilizes advanced equipment and employs dedicated scientists to provide a range of life science products and services. Intact Genomics focuses on large insert DNA cloning, manipulation, and bacterial artificial chromosome library services, facilitating scientists' exploration of the genome structure and function across various microorganisms, plants, and animal species.
Isto Technologies
Grant in 2015
ISTO Technologies, Inc., an orthobiologics company, develops biologic products to regenerate and restore function to damaged cartilage and bone. It offers InQu, a resorbable bone graft extender and substitute; NuQu, a cell-based injectable therapy for disc regeneration; and DeNovo ET, an engineered cartilage implant for the repair and regeneration of knee cartilage. The company provides its products through distributors. ISTO Technologies, Inc. was founded in 1997 and is based in St. Louis, Missouri.
TCARE, Inc. is a company that specializes in developing a caregiver support software-as-a-service (SaaS) solution aimed at preventing family caregiver burnout. Founded in 2017 and based in Saint Louis, Missouri, TCARE offers a cloud-based technology suite that allows care professionals to assess risk factors associated with caregiver burnout and implement timely interventions. Its platform serves various stakeholders, including organizations, care professionals, and family caregivers across the United States. By providing an evidence-based support program, TCARE not only aids in delaying or preventing nursing home placements but also helps reduce long-term care claims for Medicaid and life insurance carriers.
Washington University School Of Medicine
Grant in 2013
Washington University School of Medicine is the medical school of Washington University in St. Louis.A leader in medical research, teaching and patient care, Washington University School of Medicine is currently ranked fourth in the nation by U.S. News & World Report. The School’s 2,100 employed and volunteer faculty physicians and clinicians -- known as Washington University Physicians -- are also medical staff members of Barnes-Jewish and St. Louis Children’s hospitals. The clinical practice group provides care to more than 430,000 children and adults at 49 clinical sites annually. Together, the institutions located on the Washington University Medical Center campus employ more than 21,000 clinicians, scientists, residents, fellows, administrators and support staff.
Isto Technologies
Grant in 2002
ISTO Technologies, Inc., an orthobiologics company, develops biologic products to regenerate and restore function to damaged cartilage and bone. It offers InQu, a resorbable bone graft extender and substitute; NuQu, a cell-based injectable therapy for disc regeneration; and DeNovo ET, an engineered cartilage implant for the repair and regeneration of knee cartilage. The company provides its products through distributors. ISTO Technologies, Inc. was founded in 1997 and is based in St. Louis, Missouri.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.